POTELIGEO Injection (ポテリジオ点滴静注20mg)

Valsts: Japāna

Valoda: angļu

Klimata pārmaiņas: すりの適正使用協議会 RAD-AR Council, Japan

Aktīvā sastāvdaļa:

Mogamulizumab(genetical recombination)

Pieejams no:

Kyowa Kirin Co.,Ltd

SNN (starptautisko nepatentēto nosaukumu):

Mogamulizumab(genetical recombination)

Zāļu forma:

injection

Lietošanas instrukcija

Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 02/2020
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
POTELIGEO INJECTION
ACTIVE INGREDIENT:
Mogamulizumab(genetical recombination)
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine acts on CCR4, a protein which appears on the surface of
cancer cells, and shows
antitumor effect by selectively damaging the cancer cells.
It is usually used in the treatment of CCR4-positive adult T-cell
leukemia-lymphoma, relapsed
or refractory CCR4-positive Peripheral T-cell lymphoma and relapsed or
refractory Cutaneous
T-cell lymphoma.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have: infection or serious myelosuppression.
If you have cardiac dysfunction or infections such as hepatitis virus
and tuberculosis, or
history of these diseases.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・For CCR4-positive adult T-cell leukemia-lymphoma, relapsed or
refractory CCR4-positive
Peripheral T-cell lymphoma : In general, for adults, administer by
intravenous drip infusion
repeated at 1 to 2 week i